theophylline in serum/plasma

From Aaushi
Jump to navigation Jump to search

Indications

Reference interval

Principle

The THEO method uses a single pack rate technique to measure theophylline. The THEO pack contains a particle reagent (PR), which is a latex particle with theophylline linked to the surface. Aggregates of these particles are formed when a theo- phylline- specific monoclonal antibody (Ab) is introduced. Theophylline present in the sample competes with the particles for the antibody, thereby decreasing the rate of aggregation. Hence, the rate of aggregation is inversely proportional to the concentration of theophylline in the sample. The rate of aggregation is measured turbidimetrically at 340 nm. The concentration is determined by means of a previously prepared lot-specific calibration curve or mathematical function.

Theophylline + PR + Ab ----> PR-Ab complex + Theophylline-Ab (absorbs at 340 nm)

Clinical significance

,Theophylline relaxes bronchial smooth muscle to relieve or prevent asthma. The drug is principally eliminated by hepatic metabolism. Theophylline is readily absorbed after oral, rectal, or parenteral administration. If the drug is taken orally without food, the blood concentration peaks within 2 hours. In children & in adults who smoke, the half-life ranges from 3 to 4 hours. Non- smoking adults in good health has an elimination half-life of about 9 hours. ,

Optimal therapeutic effect of theophylline, as evaluated by forced expiratory volume measurements, appears to occur at plasma concentrations of 5-20 ug/mL. Suppression of exercise-induced bronchospasm in the asthmatic patient is optimal at 15 ug/mL. Neonatal apnea treated with theophylline responds to slightly lower concentrations.

Specimen

Patient preparation: No special patient preparation is required.

Minimum sample size 0.6 mL: with an optimum size of 1.5 mL or larger.

More general terms

More specific terms

Additional terms

References

  1. Kaplan, L., & Pesce, A., Clinical Chemistry:theory, analysis, & correlation, C. V. Mosby Co., St. Louis, MO., 1984, pp. 1389.
  2. Tietz, N., Fundamentals of Clinical Chemistry, 3rd edition W. B. Saunders Co., Philadelphia, 1987, pp. 859.
  3. Tietz, N., Textbook of Clinical Chemistry, W. B. Saunders Co., Philadelphia, 1986, pp. 1647.
  4. ACA IV Discrete Clinical Analyzer Instrument Manual, Volume 1:Operation, DuPont Company, Wilmington, Delaware, 1984.
  5. ACA IV Discrete Clinical Analyzer Instrument Manual, Volume 3:Chemistry, DuPont Company, Wilmington, Delaware, 1984.
  6. Theophylline Laboratory Test Directory ARUP: http://www.aruplab.com/guides/ug/tests/0090265.jsp